News Release 2017 April 11, 2017 Kyorin acquired licenses from Merck & Co., Inc., Kenilworth, N.J., U.S.A. for Investigational Therapy for Overactive Bladder (Code:KRP-114V) in Asia February 22, 2017 Change of Representative Director and President at ActivX Biosciences, Inc. January 11, 2017 Conclusion of Agreement on Business Alliance for Sale of Hand-Sanitizers 1
